Metabolic differences among newborns born to mothers with a history of leukemia or lymphoma

2Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Leukemia and lymphoma are cancers affecting children, adolescents, and young adults and may affect reproductive outcomes and maternal metabolism. We evaluated for metabolic changes in newborns of mothers with a history of these cancers. Methods: A cross-sectional study was conducted on California births from 2007 to 2011 with linked maternal hospital discharge records, birth certificate, and newborn screening metabolites. History of leukemia or lymphoma was determined using ICD-9-CM codes from hospital discharge data and newborn metabolite data from the newborn screening program. Results: A total of 2,068,038 women without cancer history and 906 with history of leukemia or lymphoma were included. After adjusting for differences in maternal age, infant sex, age at metabolite collection, gestational age, and birthweight, among newborns born to women with history of leukemia/lymphoma, several acylcarnitines were significantly (p

Cite

CITATION STYLE

APA

Anand, S. T., Ryckman, K. K., Baer, R. J., Charlton, M. E., Breheny, P. J., Terry, W. W., … Chrischilles, E. A. (2022). Metabolic differences among newborns born to mothers with a history of leukemia or lymphoma. Journal of Maternal-Fetal and Neonatal Medicine, 35(25), 6751–6758. https://doi.org/10.1080/14767058.2021.1922378

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free